MTOR and nasopharyngeal carcinoma: Based on the sensitivity to LY294002 and rapamycin, we classified NPC cells into two categories: sensitive (5-8F and 6–10B) and insensitive (S26 and CNE2), and evaluated their responses to PI3K/Akt/mTOR inhibitors.